Hybridoma MAb13
Company
Becton, Dickinson and Company
Use
Applications in research, diagnostics, and treatment due to its effects on cell attachment, spreading, and migration
Features
Antibodies specifically target human α5 β1 integrins which play a significant role in wound healing and tumor growth
NIH Contribution
Producing the actual cells by fusing spleen cells and cancer cells
HHS Institute/Agency
NIDCR
Inventor(s)
K. Yamada
Year
1993
Tech Cat
Research Reagent
